Etiology, Prevention and Therapy Navigation of Cancer
Overview
Tab Title Description
Study type
ObservationalDescribes the nature of a clinical study. Types include:
- Observational study — observes people and measures outcomes without affecting results.
- Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
- Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
Study IDs
Site IRB
- Rochester, Minnesota: 22-008878
- Jacksonville, Florida: 22-008878
- Scottsdale/Phoenix, Arizona: 22-008878
NCT ID: NCT06008392
Sponsor Protocol Number: INTERCEPTioN
About this study
The purpose of this study is to evaluate the integration of cancer pan-genetic testing into a cancer clinical practice and understand both its use and effect in “real world” practice conditions.
Participation eligibility
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.
Inclusion Criteria - Group A Germline and Somatic Testing:
- Has Mayo Clinic medical record number.
- Confirmed cancer diagnosis which is either recurrent, relapsed, refractory, metastatic, or advanced.
- Participant aware of cancer diagnosis.
- Able to provide informed consent.
- ≥ 18 years old.
- Ability to provide blood, saliva, bone marrow aspirate or hair follicle sample.
- Ability to provide archived tissue.
- NOTE: if tissue unavailable participant may still enroll onto the study for the germline collection.
Exclusion Criteria:
- Individuals who have situations that would limit compliance with the study requirements.
- Institutionalized (i.e., Federal Medical Prison).
- Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment AND/OR
- Prior somatic tissue (250+ gene) testing within the prior 3 months of enrollment.
- NOTE: Women, who are pregnant, or planning to become pregnant, can take part in this study.
Inclusion Criteria - Group B Germline Testing Only:
- Has Mayo Clinic medical record number.
- Confirmed cancer diagnosis.
- Participant aware of cancer diagnosis.
- Able to provide informed consent.
- ≥ 18 years old.
- Ability to provide blood, saliva, or hair follicle sample.
Exclusion Criteria:
- Individuals who have situations that would limit compliance with the study requirements.
- Institutionalized (i.e. Federal Medical Prison).
- Prior germline genetic testing with a 100+ multi-gene panel within the last 1 year of enrollment.
Eligibility last updated 12/28/23. Questions regarding updates should be directed to the study team contact.
Participating Mayo Clinic locations
Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.
| Mayo Clinic Location |
Status |
Contact |
Rochester, Minn.
Mayo Clinic principal investigator Mrinal Patnaik, M.B.B.S. |
Open for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
Jacksonville, Fla.
Mayo Clinic principal investigator Jeremy Jones, M.D. |
Open for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
Scottsdale/Phoenix, Ariz.
Mayo Clinic principal investigator Niloy Jewel Samadder, M.D. |
Open for enrollment |
Contact information:
Cancer Center Clinical Trials Referral Office
(855) 776-0015
|
More information
Publications
Publications are currently not available